Zhang Xiaozhang, Zhou Ningning, Yang Chunsheng, Jin Zhaowei, Guo Jeremy
Drug Product Development, WuXi Biologics (Shanghai) Co., Ltd, 190 Hedan Road, Waigaoqiao Free Trade Zone, Shanghai, 200131, China.
Antib Ther. 2023 Dec 29;7(1):67-76. doi: 10.1093/abt/tbad031. eCollection 2024 Jan.
Lyophilized drug products with high protein concentration often perform long reconstitution time, which is inconvenient for clinical use. The objective of this work is to achieve short reconstitution time with multiple and combined strategies.
Here, we describe the following approaches that lead to reduction of reconstitution time, including adding annealing step, decreasing headspace pressure, decreasing protein concentration with reducing diluent volume, increasing high surface-area-to-height ratio of the cakes, increasing frequency of swirling and diluent temperature.
Among these strategies, reducing diluent volume to achieve high protein concentration and reducing headspace pressure show markedly reduction of reconstitution time. Moreover, we propose combined strategies to mitigate the reconstitution time, at the same time, to achieve same target dose in clinics.
Therefore, this paper provides insights on the application of multiple strategies to accelerate the reconstitution of lyophilized drug products with high concentration, and facilitates their widespread clinical application.
高蛋白浓度的冻干药品通常复溶时间较长,这给临床使用带来不便。本研究的目的是通过多种联合策略实现较短的复溶时间。
在此,我们描述了以下可缩短复溶时间的方法,包括增加退火步骤、降低顶空压力、通过减少稀释剂体积降低蛋白质浓度、增加药饼的高比表面积、增加涡旋频率和提高稀释剂温度。
在这些策略中,减少稀释剂体积以达到高蛋白浓度和降低顶空压力可显著缩短复溶时间。此外,我们提出联合策略以缩短复溶时间,同时在临床上达到相同的目标剂量。
因此,本文为应用多种策略加速高浓度冻干药品的复溶提供了见解,并促进其在临床上的广泛应用。